Market Analysis of Immunosuppressive Agents in China from 2004 to 2006 / 中国药房

OBJECTIVE: To provide references for clinical rational and safe use of immunosuppressant agents. METHODS: The data regarding the consumption quantity and consumption sum of the immunosuppressant agents were retrieved from "China medical economy information network" ( "menet" ), which were analyzed and compared with the pertinent literature both at home and abroad. RESULTS & CONCLUSIONS: From 2004 to 2006, dominating the first 3 places in respect of consumption quantity and consumption sum were mycophenolate mofetil, ciclosporin, and tarcolimus. And tacrolimus is expected to become the choice drug for organ transplantation.